Evaluation of a human adenovirus viral load assay using the Altona RealStar® PCR test Academic Article uri icon


MeSH Major

  • Anti-Bacterial Agents
  • Bacteremia
  • Carbapenems
  • Enterobacteriaceae


  • © 2017 Elsevier Inc. This study evaluated the performance of the Altona Diagnostics RealStar® Adenovirus Research Use Only (RUO) real-time PCR reagents for HAdV quantitation in plasma samples from immunodeficient patients. The assay was linear from 2.30–9.17 log 10 copies/mL (coefficient of determination; R 2 = 0.998) with limits of detection and quantification of 2.19 log 10 and 2.30 log 10 copies/mL ( > 95% positivity rate), respectively. Assay precision was highly reproducible with coefficients of variance ranging from 0% to 4.7%. A comparison of 66 matched samples showed good agreement (R 2 = 0.845) between the Altona and the reference laboratory assay, with an average negative bias (−0.24 log 10 copies/mL). Genotyping analysis demonstrated that HAdV species B and C accounted for 77% of the positive samples. A significant (≥0.9 log 10 ) difference in quantitation between both tests was found for three HAdV types (HAdV types A12, B14 and F41). In conclusion, the Altona RealStar® test is a reliable and sensitive assay for HAdV DNA quantitation.

publication date

  • April 2018



  • Academic Article



  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.diagmicrobio.2017.11.016

PubMed ID

  • 29433999

Additional Document Info

start page

  • 257

end page

  • 263


  • 90


  • 4